GAMMA Investing LLC Buys 845 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

GAMMA Investing LLC boosted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 98.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,701 shares of the company’s stock after buying an additional 845 shares during the quarter. GAMMA Investing LLC’s holdings in Privia Health Group were worth $31,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Canada Pension Plan Investment Board bought a new stake in shares of Privia Health Group during the second quarter valued at approximately $26,000. Nisa Investment Advisors LLC raised its position in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after purchasing an additional 930 shares in the last quarter. Signaturefd LLC raised its position in Privia Health Group by 46.3% during the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after purchasing an additional 626 shares in the last quarter. Park Place Capital Corp grew its position in shares of Privia Health Group by 115.4% during the 1st quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after buying an additional 1,335 shares in the last quarter. Finally, Covestor Ltd grew its position in shares of Privia Health Group by 25.5% during the 1st quarter. Covestor Ltd now owns 5,292 shares of the company’s stock worth $104,000 after buying an additional 1,076 shares in the last quarter. 94.48% of the stock is owned by hedge funds and other institutional investors.

Privia Health Group Stock Down 3.3 %

PRVA opened at $17.83 on Friday. The company has a market cap of $2.13 billion, a P/E ratio of 118.87, a price-to-earnings-growth ratio of 4.15 and a beta of 0.76. The firm’s 50-day moving average price is $18.79 and its 200-day moving average price is $18.30. Privia Health Group, Inc. has a 52-week low of $15.92 and a 52-week high of $24.35.

Privia Health Group (NASDAQ:PRVA) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The company had revenue of $422.30 million during the quarter, compared to analysts’ expectations of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The company’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.06 EPS. On average, research analysts anticipate that Privia Health Group, Inc. will post 0.16 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 14.20% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on PRVA shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $28.00 price objective on shares of Privia Health Group in a research note on Wednesday, August 14th. Robert W. Baird upped their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. KeyCorp began coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective on the stock. Finally, Evercore ISI dropped their target price on Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 9th. Two investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Privia Health Group has an average rating of “Buy” and an average target price of $24.73.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.